5 Must-Know Facts About Allergan's $66B Actavis Tie-Up
Allergan Inc. on Monday sketched out a $66 billion union with fellow drugmaker Actavis PLC, the white knight providing the long-sought target leverage to upend a high-profile hostile buyout campaign mounted...To view the full article, register now.
Already a subscriber? Click here to view full article